Amrize (AMRZ) EBITDA Margin (2024 - 2026)

Amrize has disclosed EBITDA Margin across 3 years of filings, most recently posting 20.35% for Q2 2026.

• In Q2 2026, EBITDA Margin fell 7.0% year-over-year to 20.35%; the TTM figure through Jun 2026 stood at 15.52% (down 200.0% YoY), while the FY2025 annual figure was 16.13%, down 262.0% from the prior year.
• EBITDA Margin came in at 20.35% for Q2 2026 at Amrize, up from 3.3% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 24.49% in Q3 2024 to a low of 3.3% in Q1 2026.
• Average EBITDA Margin over 3 years is 15.75%, with a median of 20.35% recorded in 2026.
• Year-over-year, EBITDA Margin slumped 332 bps in 2025 and declined 7 bps in 2026.
• Over 3 years, EBITDA Margin stood at 18.85% in 2024, then decreased by 11 bps to 16.73% in 2025, then rose by 22 bps to 20.35% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 20.35% in Q2 2026, 3.3% in Q1 2026, and 16.73% in Q4 2025.